First-Line Treatment for Primary Breast Diffuse Large B-Cell Lymphoma Using Immunochemotherapy and Central Nervous System Prophylaxis: A Multicenter Phase 2 Trial

There are limited data from prospective controlled trials regarding optimal treatment strategies in patients with primary breast diffuse large B-cell lymphoma (DLBCL). In this phase 2 study (NCT01448096), we examined the efficacy and safety of standard immunochemotherapy and central nervous system (...

Descripción completa

Detalles Bibliográficos
Autores principales: Yhim, Ho-Young, Yoon, Dok Hyun, Kim, Seok Jin, Yang, Deok-Hwan, Eom, Hyeon-Seok, Kim, Kyoung Ha, Park, Yong, Kim, Jin Seok, Kim, Hyo Jung, Suh, Cheolwon, Kim, Won Seog, Kwak, Jae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463683/
https://www.ncbi.nlm.nih.gov/pubmed/32781541
http://dx.doi.org/10.3390/cancers12082192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463683/
https://www.ncbi.nlm.nih.gov/pubmed/32781541
http://dx.doi.org/10.3390/cancers12082192

Ejemplares similares